Invention Grant
- Patent Title: Angiotensin II receptor antagonists
- Patent Title (中): 血管紧张素II受体拮抗剂
-
Application No.: US12000247Application Date: 2007-12-11
-
Publication No.: US07880014B2Publication Date: 2011-02-01
- Inventor: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
- Applicant: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
- Applicant Address: US NJ Rahway FR Valbonne
- Assignee: Merck Sharp & Dohme Corp.,NiCox S.A.
- Current Assignee: Merck Sharp & Dohme Corp.,NiCox S.A.
- Current Assignee Address: US NJ Rahway FR Valbonne
- Agency: Convington & Burling LLP
- Agent Paul J. Berman; Melody Wu
- Main IPC: C07D257/00
- IPC: C07D257/00 ; C07D403/00

Abstract:
A compound having the structure wherein R is an angiotensin receptor antagonist active group, Y is -Y1-Y2-Y3-Y4-Y5-; Y1 is C(R1R2); R1 is selected from the group consisting of hydrogen and C1-4 alkyl; R2 is selected from the group consisting of hydrogen, C1-4 alkyl, and —OC(O)C1-4 alkyl; Y2 is O or CH2; Y3 is C(O) or CH2; Y4 is O or CH2; Y5 is —(CH2)1-2—(X)0-1—(CH2)0-1— or is absent; X is —O— or —CR3R4—; and R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
Public/Granted literature
- US20080194660A1 Angiotensin II receptor antagonists Public/Granted day:2008-08-14
Information query